Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia.

Hillgruber C, Pöppelmann B, Weishaupt C, Steingräber AK, Wessel F, Berdel WE, Gessner JE, Ho-Tin-Noé B, Vestweber D, Goerge T.

J Exp Med. 2015 Jul 27;212(8):1255-66. doi: 10.1084/jem.20142076. Epub 2015 Jul 13.

2.

Blocking von Willebrand factor for treatment of cutaneous inflammation.

Hillgruber C, Steingräber AK, Pöppelmann B, Denis CV, Ware J, Vestweber D, Nieswandt B, Schneider SW, Goerge T.

J Invest Dermatol. 2014 Jan;134(1):77-86. doi: 10.1038/jid.2013.292. Epub 2013 Jun 28.

3.

New tools for assessing the individual risk of metastasis in renal cell carcinoma.

Herrmann E, Weishaupt C, Pöppelmann B, Hillgruber C, Pühse G, Krabbe LM, Feld M, Steinhoff M, Goerge T.

Clin Exp Metastasis. 2013 Feb;30(2):215-24. doi: 10.1007/s10585-012-9529-6. Epub 2012 Aug 23.

PMID:
22915161
4.

Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation.

Gorzelanny C, Pöppelmann B, Pappelbaum K, Moerschbacher BM, Schneider SW.

Biomaterials. 2010 Nov;31(33):8556-63. doi: 10.1016/j.biomaterials.2010.07.100. Epub 2010 Aug 24.

PMID:
20797781
5.

The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells.

Kerk N, Strozyk EA, Pöppelmann B, Schneider SW.

J Invest Dermatol. 2010 Sep;130(9):2259-68. doi: 10.1038/jid.2010.136. Epub 2010 May 27.

6.

Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells.

Gorzelanny C, Pöppelmann B, Strozyk E, Moerschbacher BM, Schneider SW.

Biomacromolecules. 2007 Oct;8(10):3035-40. Epub 2007 Sep 11.

PMID:
17845054
7.

Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.

Goerge T, Barg A, Schnaeker EM, Poppelmann B, Shpacovitch V, Rattenholl A, Maaser C, Luger TA, Steinhoff M, Schneider SW.

Cancer Res. 2006 Aug 1;66(15):7766-74.

8.

Differential effects of NF-kappaB on apoptosis induced by DNA-damaging agents: the type of DNA damage determines the final outcome.

Strozyk E, Pöppelmann B, Schwarz T, Kulms D.

Oncogene. 2006 Oct 12;25(47):6239-51. Epub 2006 May 15.

PMID:
16702954
9.

NF{kappa}B-dependent down-regulation of tumor necrosis factor receptor-associated proteins contributes to interleukin-1-mediated enhancement of ultraviolet B-induced apoptosis.

Pöppelmann B, Klimmek K, Strozyk E, Voss R, Schwarz T, Kulms D.

J Biol Chem. 2005 Apr 22;280(16):15635-43. Epub 2005 Feb 21.

11.

Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1).

Kulms D, Düssmann H, Pöppelmann B, Ständer S, Schwarz A, Schwarz T.

Cell Death Differ. 2002 Jun;9(6):598-608.

12.
13.

Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation.

Kulms D, Pöppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T.

Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7974-9.

14.

Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand.

Kothny-Wilkes G, Kulms D, Pöppelmann B, Luger TA, Kubin M, Schwarz T.

J Biol Chem. 1998 Oct 30;273(44):29247-53.

15.

Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.

Aragane Y, Kulms D, Metze D, Wilkes G, Pöppelmann B, Luger TA, Schwarz T.

J Cell Biol. 1998 Jan 12;140(1):171-82.

16.

Transforming growth factor-alpha induces interleukin-6 in the human keratinocyte cell line HaCaT mainly by transcriptional activation.

Aragane Y, Yamada H, Schwarz A, Poppelmann B, Luger TA, Tezuka T, Schwarz T.

J Invest Dermatol. 1996 Jun;106(6):1192-7.

Supplemental Content

Loading ...
Support Center